Pharmacological properties of -mangostin, a novel histamine H 1 receptor antagonist

By Chairungsrilerd N.   Furukawa K.-I.   Ohta T.   Nozoe S.   Ohizumi Y.  

European Journal of Pharmacology, Vol. 314, Iss. 3, 1996-10 ,pp. : 351-356

Elsevier

Access to resources Recommend Favorite

Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H-Receptor Antagonist, in Patients with Seasonal Allergic Rhinitis: Assessment during the Spring and Fall Allergy Seasons

By Meltzer E.O.  

Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. : 25-32

Adis International

Access to resources Recommend Favorite

Preclinical Pharmacology of Bilastine, a New Selective Histamine H1 Receptor Antagonist: Receptor Selectivity and in Vitro Antihistaminic Activity

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustin   Orjales Aurelio  

Drugs in R&D, Vol. 6, Iss. 6, 2005-01 ,pp. : 371-384

Adis International

Access to resources Recommend Favorite

Randomized Clinical Study of a Histamine H 3 Receptor Antagonist for the Treatment of Adults with Attention-Deficit Hyperactivity Disorder

By Weisler Richard H.   Pandina Gahan J.   Daly Ella J.   Cooper Kimberly   Gassmann-Mayer Cristiana  

CNS Drugs, Vol. 26, Iss. 5, 2012-05 ,pp. : 421-434

Adis International

Access to resources Recommend Favorite

In Vivo Pharmacological Characterisation of Bilastine, a Potent and Selective Histamine H 1 Receptor Antagonist

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustín   Orjales Aurelio  

Drugs in R&D, Vol. 7, Iss. 4, 2006-01 ,pp. : 219-231

Adis International

Access to resources Recommend Favorite